You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Patent: 8,853,412


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,853,412
Title:Pyrrolidinone derivatives as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
Abstract: The present invention relates to pyrrolidinone derivatives. The pyrrolidinone derivatives are GPR119 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of pyrrolidinone derivatives as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.
Inventor(s): Schwink; Lothar (Frankfurt am Main, DE), Bossart; Martin (Frankfurt am Main, DE), Glombik; Heiner (Frankfurt am Main, DE), Gossel; Matthias (Frankfurt am Main, DE), Kadereit; Dieter (Frankfurt am Main, DE), Klabunde; Thomas (Frankfurt am Main, DE), Maier; Thomas (Frankfurt am Main, DE), Stengelin; Siegfried (Frankfurt am Main, DE)
Assignee: Sanofi (Paris, FR)
Application Number:14/048,425
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive Analysis of the Claims and Patent Landscape for United States Patent 8,853,412

Introduction

United States Patent 8,853,412, like any other patent, is a complex document that requires a thorough analysis to understand its claims, implications, and position within the broader patent landscape. This analysis will delve into the key aspects of the patent, including the claims, the examination process, and the relevant legal and technological contexts.

Understanding the Patent Claims

To analyze the claims of US Patent 8,853,412, it is crucial to break down the patent into its core components. Here are the steps involved:

Claim Structure

Patent claims are the heart of any patent application, defining the scope of the invention. They must be clear, concise, and supported by the specification. The claims can be divided into independent and dependent claims, each serving a different purpose. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Claim Interpretation

Interpreting the claims involves understanding the language used and the context provided by the specification. The doctrine of equivalents and prosecution history estoppel are important considerations here, as they can affect the scope of the claims during litigation[3].

The Examination Process

The journey of a patent from application to grant involves a rigorous examination process.

Overview of the Examination Process

The USPTO examines patent applications to ensure they meet the criteria of novelty, nonobviousness, utility, and adequate disclosure. This process includes initial reviews, office actions, and potential continuations or appeals[1].

Allowance Rates and Continuations

The probability of a patent being granted can be influenced by various factors, including the technology field and the type of applicant (small vs. large entity). Continuation procedures, such as Request for Continued Examination (RCE) and divisional applications, can significantly impact the allowance rates and the complexity of tracking the application's history[1].

Subject Matter Eligibility

Subject matter eligibility is a critical aspect of patent law, particularly in the context of emerging technologies like AI.

The Two-Pronged Framework

Under 35 U.S.C. § 101, the USPTO uses a two-pronged framework to determine subject matter eligibility. Prong One assesses whether the claim recites an abstract idea, and if so, Prong Two evaluates whether the claim integrates the abstract idea into a practical application. For AI inventions, demonstrating a specific, concrete technological advancement is crucial[2].

Practical Applicability Analysis

To overcome section 101 rejections, it is essential to show that the claims reflect an improvement in the functioning of a computer or another technical field. This involves a detailed technical explanation in the specification and a clear narrative highlighting the practical utility and real-world impact of the invention[2].

AI and Patent Law

The integration of AI in patent applications and inventions has introduced new challenges and opportunities.

AI-Assisted Inventions

The 2024 Guidance Update from the USPTO clarifies that AI inventions are patentable if one or more persons made a significant contribution to the claimed invention. However, the use of AI tools in drafting specifications and claims must be carefully managed to ensure accuracy and compliance with legal standards[5].

Inventorship and AI Contributions

When AI systems contribute to the drafting of patent documents, practitioners must assess whether these contributions rise to the level of inventorship. Ensuring the accuracy of factual assertions and avoiding inaccurate statements or omissions is paramount[5].

Technological Context

The technological field in which the patent operates is vital for understanding its significance and potential impact.

Technology Fields and Allowance Rates

Different technology fields have varying allowance rates. For example, applications in the Chemical and Drugs and Medical fields may have different outcomes compared to those in Electrical and Electronics or Computers and Communications. Understanding these dynamics can help in strategizing the patent application process[1].

Industry Impact

Patents in emerging technologies like AI can have a profound impact on industry practices and innovation. Demonstrating practical applicability and real-world impact is crucial for securing patents in these fields[2].

Legal and Regulatory Framework

The legal framework governing patents is complex and evolving.

Statutory Requirements

Patents must meet the statutory requirements of originality, novelty, utility, and nonobviousness. The America Invents Act of 2011 introduced significant changes to patent law, including the switch to a first-to-file system[3].

Judicial and Administrative Guidance

The USPTO's guidance, while informative, does not carry the force of law. Judicial decisions, particularly from the Federal Circuit and the Supreme Court, are binding and often clarify the application of patent law[2].

Case Law and Precedents

Understanding relevant case law is essential for navigating the patent landscape.

Chisum on Patents

Resources like Chisum on Patents provide comprehensive analysis of patent law, including doctrines, rules, and case law. This treatise is invaluable for practitioners seeking to understand the legal nuances and precedents that shape patent law[3].

Federal Circuit Decisions

Decisions from the Federal Circuit often provide clarity on patent eligibility and other critical issues. These decisions can significantly influence the strategy for patent applications and litigation[2].

Search and Analysis Tools

Effective patent search and analysis are crucial for understanding the patent landscape.

USPTO Resources

The USPTO provides various tools, such as the Patent and Trademark Resource Centers (PTRCs) and the Electronic Official Gazette, to help in searching and analyzing patents. The Common Citation Document (CCD) application is particularly useful for consolidating prior art citations from multiple offices[4].

Key Takeaways

  • Claims Analysis: Understanding the structure and interpretation of patent claims is fundamental.
  • Examination Process: The examination process, including continuations and appeals, significantly impacts the patent's journey.
  • Subject Matter Eligibility: Demonstrating practical applicability is crucial for overcoming section 101 rejections, especially in AI inventions.
  • AI Integration: AI-assisted inventions must comply with legal standards regarding inventorship and accuracy.
  • Technological Context: The technological field and industry impact are vital for strategizing and understanding the patent's significance.
  • Legal Framework: Statutory requirements, judicial decisions, and administrative guidance all play critical roles in shaping patent law.

Frequently Asked Questions (FAQs)

1. What are the key factors that influence the probability of receiving a US patent?

The probability of receiving a US patent is influenced by factors such as the technology field, the type of applicant (small vs. large entity), and the use of continuation procedures.

2. How does the USPTO determine subject matter eligibility for AI inventions?

The USPTO uses a two-pronged framework under 35 U.S.C. § 101, focusing on whether the claim integrates an abstract idea into a practical application, particularly demonstrating an improvement in the functioning of a computer or another technical field.

3. Can AI systems contribute to the inventorship of a patent?

AI systems can assist in drafting patent documents, but the contributions must be assessed to ensure they rise to the level of inventorship. Natural persons must make significant contributions to the claimed invention.

4. What are the implications of the 2024 Guidance Update for AI inventions?

The 2024 Guidance Update clarifies that AI inventions are patentable and emphasizes the importance of demonstrating practical applicability and real-world impact to overcome section 101 rejections.

5. How can practitioners ensure compliance with legal standards when using AI tools in patent applications?

Practitioners must verify the accuracy of factual assertions, ensure that AI contributions do not introduce inaccurate statements or omit material information, and comply with USPTO guidance on the use of AI tools.

Sources Cited

  1. Hegde, D., & Carley, M. (n.d.). What Is the Probability of Receiving a US Patent?. Retrieved from https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  2. Baker Botts. (2024, August 26). The Importance of Prong Two of Step 2A for AI Inventions. Retrieved from https://www.bakerbotts.com/thought-leadership/publications/2024/september/the-importance-of-prong-two-of-step-2a-for-ai-inventions
  3. LexisNexis. (n.d.). Chisum on Patents. Retrieved from https://store.lexisnexis.com/products/chisum-on-patents-skuusSku10111
  4. USPTO. (2018, October 18). Search for patents. Retrieved from https://www.uspto.gov/patents/search
  5. Buchanan Ingersoll & Rooney PC. (2024, April 15). U.S. Patent Office Issues Additional Guidance on Use of AI Tools. Retrieved from https://www.bipc.com/united-states-patent-office-issues-guidance-on-use-of-ai-tools

More… ↓

⤷  Subscribe

Details for Patent 8,853,412

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Chiesi Farmaceutici S.p.a. MYALEPT metreleptin For Injection 125390 February 24, 2014 ⤷  Subscribe 2032-10-09
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.